Friday, October 25, 2024 | 8 a.m. to noon | Edina, Minnesota

A MULTIDISCIPLINARY EVENT FOR PHYSICIANS AND HEALTHCARE PROVIDERS

Physicians working in the lung cancer space – please join us for the first-ever Minnesota Biomarker Summit, held in Edina, MN, on Friday, October 25, from 8 a.m. to noon. Networking meals will be available at 7 a.m. and noon. There is no cost to attend this event. 

Along with a dedicated group of lung cancer experts from healthcare systems in MN, ABOH will host this summit to engage and update oncologists, pathologists, and other medical professionals who are responsible within their system for making decisions about treatments or ordering biomarker testing for newly diagnosed lung cancer patients.

Thank you to our sponsors!

Platinum Sponsors ($10,000)

Bronze Sponsors ($1500)

Puma Biotechnology, Inc.

Event Itinerary

7 a.m. – Networking Breakfast/Exhibitor Tables (optional)

8 a.m. – Early, Broad-based Biomarker Testing – Essential for Determining Optimal NSCLC Treatment

(Bruce Johnson, MD, Chief Clinical Research Officer and Institute Physician at the Dana Farber Cancer Institute and Brigham and Women’s Hospital, Professor Emeritus of Medicine at Harvard Medical School)

9:30 a.m. – How to Test? Blood vs Tissue and Recommended Panel Size

(Ying-Chun Lo, MD, PhD, Assistant Professor and Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic; and Andrew Nelson, MD, PhD, Department of Laboratory Medicine and Pathology, University of Minnesota)

11 a.m. – How to Implement Reflex Biomarker Testing in Your Healthcare System

(Overcoming hospital and clinical workflow barriers to testing. Panel: Oncologists from Mayo Clinic, University of Minnesota, Allina Health, Rural Cancer Institute, Lakewood Health, Minneapolis VA, and more! Emcee: Abbie Begnaud, MD, University of Minnesota)

Noon – Lunch/Brainstorming Session (optional)

(Brainstorm tactics that will facilitate and support clinicians to order appropriate and timely biomarker tests, plus ACS update on newly passed MN Biomarker Bill!)

• Fill out the Interest Form
• Eligible participants will receive a confirmation email with event details. A virtual option is available, but only during presentations.

Pharma representatives whose companies sponsor the event will be invited to join us at this event and be part of the conversation. The sponsor benefit chart below shows the benefits received at each gift level and the number of guests.

• Sponsor benefit chart

Our specific goals for hosting this biomarker summit:

1. Encourage collaboration among medical professionals to build a Minnesota healthcare community that understands the importance of precision medicine in lung cancer, feels comfortable testing and identifying the best therapy, and commits to helping their healthcare system develop a systemwide practice of reflex biomarker testing.
2. Increase the number of MN lung cancer patients receiving biomarker testing. Biomarker testing/molecular profiling ensures lung cancer patients get the right treatment at the right time. Biomarker testing is not always ordered for metastatic lung cancer patients – let’s talk about solutions to overcome the barriers.

*This event is open to physicians working in the lung cancer space. If you are a lung cancer patient or caregiver, you are invited to attend the Midwest Lung Cancer Patient Summit on September 28. More information regarding that event here. 

NOTE: A Breath of Hope hosts one the most visited patient education programs in the world (Animated Patient’s Guide to Lung Cancer found at youandlungcancer.com), funds translational U.S. research, provides patient support services, and works to address areas of concern, such as screening and biomarker testing.

Every step we take is A Breath of Hope for the thousands of Minnesota families that lose their loved ones to lung cancer each year. We hope you can join us!